Breast Cancer
Oncologists, primary care clinicians should be aware of BRCA testing indications in men
Greater utilization of genetic testing among men could have considerable benefits with regard to detection, risk management and personalized treatment of cancers, according to authors of a review published in JAMA Oncology.
Manuka honey shows ‘very surprising’ potential to reduce breast cancer tumor growth
Manuka honey may represent an alternative natural approach to reducing tumor growth in breast cancer, according to research conducted at UCLA Health Jonsson Comprehensive Cancer Center.
AACR report highlights dramatic improvement in outcomes for children, adolescents
The development of more effective treatments — including personalized therapies — have dramatically improved outcomes for children and adolescents with cancer, according to American Association for Cancer Research’s Cancer Progress Report.
Q&A: When to use digital breast tomosynthesis for cancer screening
Mammography and digital breast tomosynthesis lead to very similar outcomes, so shared-decision making is important for breast cancer screening, according to an expert.
False-positive results linked to lower likelihood of further cancer screenings
False-positive mammography results discouraged women to return for further screenings, results from an observational cohort study published in the Annals of Internal Medicine showed.
Pembrolizumab regimen extends OS in triple-negative breast cancer
Use of pembrolizumab with neoadjuvant chemotherapy and as monotherapy in the adjuvant setting extended OS for patients with early-stage triple-negative breast cancer, according to results from the randomized phase 3 KEYNOTE-522 trial.
Novel AI model may predict which patients with cancer are at risk for chronic pain
A multi-institutional team of researchers developed an AI model designed to predict which patients with breast cancer are most likely to experience chronic pain.
Clinicians ‘should be open’ to menopausal hormone therapy beyond age 65 years
CHICAGO — Hormone therapy is beneficial for some women beyond age 65 years to treat ongoing menopausal symptoms that affect their quality of life, according to research reported at the Annual Meeting of The Menopause Society.
Medical oncologist and cancer survivorship expert to receive ESMO Award
Ann H. Partridge, MD, MPH, will receive this year’s ESMO Award.
VIDEO: Sequence of treatments for patients with breast cancer ‘continues to evolve’
In this video interview, Sara M. Tolaney, MD, MPH, discusses the individualized sequential therapies provided to patients based on the breast cancer subtype, genomics and other factors.